|
| | 9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID Basic information |
| Product Name: | 9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID | | Synonyms: | 5-hydroxy-2-(3-hydroxy-1-octenyl)-3-oxo-cyclopentaneheptanoicaci;5-hydroxy-2-(3-hydroxy-1-octenyl)-3-oxocyclopentaneheptanoicacid;9,15-dihydroxy-11-oxo-,(9-alpha,13e,15s)-prost-13-en-1-oicaci;pgd1;PROSTAGLANDIN D1;7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]heptanoic acid;(13E,15S)-9α,15-Dihydroxy-11-oxoprost-13-en-1-oic acid;11-DehydroPGF1α | | CAS: | 17968-82-0 | | MF: | C20H34O5 | | MW: | 354.48 | | EINECS: | | | Product Categories: | | | Mol File: | 17968-82-0.mol |  |
| | 9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID Chemical Properties |
| Melting point | 64.5-65.5 °C | | Boiling point | 544.6±50.0 °C(Predicted) | | density | 1.131±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: >100 mg/ml (from PGD2); DMSO: >50 mg/ml (from PGD2); Ethanol: >75 mg/ml (from PGD2); PBS pH 7.2: >5 mg/ml (from PGD2) | | pka | 4.78±0.10(Predicted) |
| | 9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID Usage And Synthesis |
| Description | Prostaglandin D1 (PGD1) is the 1-series analog of PGD2 . It is an inhibitor of ADP-induced platelet aggregation in humans with an IC50 value of 320 ng/ml, about 1/10 as potent as PGD2. | | Uses | Prostaglandin D1 is used in pharmalogical and in functional characterization of novel EP & DP receptor agonist: DPI receptor mediates penile erection in multiple species. | | Definition | ChEBI: Prostaglandin D1 is a prostaglandins D. It has a role as a human metabolite. It is a conjugate acid of a prostaglandin D1(1-). |
| | 9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID Preparation Products And Raw materials |
|
